Center for Substance Abuse Prevention; Notice of Meeting, 1708 [2012-246]

Download as PDF 1708 Federal Register / Vol. 77, No. 7 / Wednesday, January 11, 2012 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration pmangrum on DSK3VPTVN1PROD with NOTICES Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will meet on January 31 and February 1, 2012. The DTAB will convene in both open and closed sessions over these two days. On January 31, 2012 from 9 a.m. to 3 p.m. EST, the meeting will be open to the public to discuss the science of synthetic opioids as potential analytes in the Mandatory Guidelines for Federal Workplace Drug Testing Programs. The public is invited to attend the open session in person or to listen via teleconference. Due to the limited seating space and call-in capacity, registration is requested. Public comments are welcome. To register, make arrangements to attend, obtain the teleconference call-in numbers and access codes, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register at the SAMHSA Advisory Committees’ Web site at https://nac.samhsa.gov/ Registration/meetingsRegistration.aspx or contact the CSAP DTAB Designated Federal Official, Dr. Janine Denis Cook (see contact information below). On January 31, 2012 between 3 p.m.– 5 p.m. EST and February 1, 2012 between 8:30 a.m. and 1 p.m. EST, the Board will meet in closed session to discuss proposed revisions to the Mandatory Guidelines for Federal Workplace Drug Testing Programs. This portion of the meeting is closed to the public as determined by the Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(9)(B) and 5 U.S.C. App. 2, Section 10(d). Substantive program information, a summary of the meeting, and a roster of DTAB members may be obtained as soon as possible after the meeting by accessing the SAMHSA Advisory Committees’ Web site, https:// www.nac.samhsa.gov/DTAB/ meetings.aspx, or by contacting Dr. Cook. The transcript for the open meeting will also be available on the SAMHSA Committee Web site within three weeks after the meeting. Committee Name: Substance Abuse and Mental Health Services VerDate Mar<15>2010 15:02 Jan 10, 2012 Jkt 226001 Administration’s Center for Substance Abuse Prevention, Drug Testing Advisory Board. Dates/Time/Type: January 31, 2012 from 9 a.m. to 3 p.m. E.S.T.: Open. January 31, 2012 from 3 p.m. to 5 p.m. E.S.T.: Closed. February 1, 2012 from 8:30 a.m. to 1 p.m. E.S.T.: Closed. Place: Sugarloaf Conference Room, SAMHSA Office Building, 1 Choke Cherry Road, Rockville, Maryland 20857. Contact: Janine Denis Cook, Ph.D., Designated Federal Official, CSAP Drug Testing Advisory Board, 1 Choke Cherry Road, Room 2–1045, Rockville, Maryland 20857, Telephone: (240) 276– 2600, Fax: (240) 276–2610, Email: janine.cook@samhsa.hhs.gov. Janine Denis Cook, Designated Federal Official, DTAB, Division of Workplace Programs, Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration. [FR Doc. 2012–246 Filed 1–10–12; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2011–1167] Cooperative Research and Development Agreement: Technology To Provide Wireless Precise Time; Alternatives to Global Positioning Systems Coast Guard, DHS. Notice of intent; request for public comments. AGENCY: ACTION: The Coast Guard is announcing its intent to enter into a Cooperative Research and Development Agreement (CRADA) with UrsaNav, Inc., to research, evaluate, and document at least one alternative to Global Positioning Systems (GPS) as a means of providing precise time. The alternative under consideration is a wireless technical approach for providing precise time using U.S. government facilities and frequency authorizations. The Coast Guard invites public comment on the proposed CRADA and also invites other nonFederal participants, who have the interest and capability to bring similar contributions to this type of research, to consider entry into similar CRADAs. DATES: Comments and related material on the proposed CRADA must either be submitted to our online docket via https://www.regulations.gov on or before February 10, 2012, or reach the Docket Management Facility by that date. SUMMARY: PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 Notifications from parties interested in participating as a non-Federal participant in a CRADA similar to the one described in this notice must reach the Docket Management Facility on or before February 10, 2012. Do not submit detailed proposals for different CRADAs to the Docket Management Facility. Instead, if you are interested in being a non-Federal participant in a different CRADA, you may submit detailed proposals to LT Helen Y. Millward, U.S. Coast Guard Research and Development Center, 1 Chelsea Street, New London, CT 06320, telephone: (860) 271–2815, email: Helen.Y.Millward@uscg.mil. You may submit written comments on this notice identified by docket number USCG–2011–1167 using any one of the following methods: (1) Federal eRulemaking Portal: https://www.regulations.gov. (2) Fax: (202) 493–2251. (3) Mail: Docket Management Facility (M–30), U.S. Department of Transportation, West Building Ground Floor, Room W12–140, 1200 New Jersey Avenue SE., Washington, DC 20590– 0001. (4) Hand delivery: Same as mail address above, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. The telephone number is (202) 366–9329. To avoid duplication, please use only one of these four methods. See the ‘‘Public Participation and Request for Comments’’ portion of the SUPPLEMENTARY INFORMATION section below for instructions on submitting comments. ADDRESSES: If you have questions concerning this notice or desire to submit a CRADA proposal, please contact LT Helen Y. Millward, U.S. Coast Guard Research and Development Center, 1 Chelsea Street, New London, CT 06320, telephone: (860) 271–2815, email: Helen.Y.Millward@uscg.mil. If you have questions on viewing or submitting material to the docket, call Ms. Renee V. Wright, Program Manager, Docket Operations, telephone (202) 366–9826. SUPPLEMENTARY INFORMATION: FOR FURTHER INFORMATION CONTACT: Public Participation and Request for Comments We encourage you to submit comments and related material on this notice. All comments received will be posted, without change, to https:// www.regulations.gov and will include any personal information you have provided. E:\FR\FM\11JAN1.SGM 11JAN1

Agencies

[Federal Register Volume 77, Number 7 (Wednesday, January 11, 2012)]
[Notices]
[Page 1708]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-246]



[[Page 1708]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will meet on January 31 and February 1, 2012. The DTAB 
will convene in both open and closed sessions over these two days.
    On January 31, 2012 from 9 a.m. to 3 p.m. EST, the meeting will be 
open to the public to discuss the science of synthetic opioids as 
potential analytes in the Mandatory Guidelines for Federal Workplace 
Drug Testing Programs.
    The public is invited to attend the open session in person or to 
listen via teleconference. Due to the limited seating space and call-in 
capacity, registration is requested. Public comments are welcome. To 
register, make arrangements to attend, obtain the teleconference call-
in numbers and access codes, submit written or brief oral comments, or 
request special accommodations for persons with disabilities, please 
register at the SAMHSA Advisory Committees' Web site at https://nac.samhsa.gov/Registration/meetingsRegistration.aspx or contact the 
CSAP DTAB Designated Federal Official, Dr. Janine Denis Cook (see 
contact information below).
    On January 31, 2012 between 3 p.m.-5 p.m. EST and February 1, 2012 
between 8:30 a.m. and 1 p.m. EST, the Board will meet in closed session 
to discuss proposed revisions to the Mandatory Guidelines for Federal 
Workplace Drug Testing Programs. This portion of the meeting is closed 
to the public as determined by the Administrator, SAMHSA, in accordance 
with 5 U.S.C. 552b(c)(9)(B) and 5 U.S.C. App. 2, Section 10(d).
    Substantive program information, a summary of the meeting, and a 
roster of DTAB members may be obtained as soon as possible after the 
meeting by accessing the SAMHSA Advisory Committees' Web site, https://www.nac.samhsa.gov/DTAB/meetings.aspx, or by contacting Dr. Cook. The 
transcript for the open meeting will also be available on the SAMHSA 
Committee Web site within three weeks after the meeting.
    Committee Name: Substance Abuse and Mental Health Services 
Administration's Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: January 31, 2012 from 9 a.m. to 3 p.m. E.S.T.: 
Open. January 31, 2012 from 3 p.m. to 5 p.m. E.S.T.: Closed. February 
1, 2012 from 8:30 a.m. to 1 p.m. E.S.T.: Closed.
    Place: Sugarloaf Conference Room, SAMHSA Office Building, 1 Choke 
Cherry Road, Rockville, Maryland 20857.
    Contact: Janine Denis Cook, Ph.D., Designated Federal Official, 
CSAP Drug Testing Advisory Board, 1 Choke Cherry Road, Room 2-1045, 
Rockville, Maryland 20857, Telephone: (240) 276-2600, Fax: (240) 276-
2610, Email: janine.cook@samhsa.hhs.gov.

Janine Denis Cook,
Designated Federal Official, DTAB, Division of Workplace Programs, 
Center for Substance Abuse Prevention, Substance Abuse and Mental 
Health Services Administration.
[FR Doc. 2012-246 Filed 1-10-12; 8:45 am]
BILLING CODE 4162-20-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.